Efficacy of fluralaner against hard tick (Rhipicephalus sanguineus) in dogs
Abstract
Fluralaner is a new molecular entity from the isoxazoline class that exhibits acaricidal and insecticidal activity and it is recommended as an anti-ticks drugs. The aim of this study is to analyze the effect of fluralaner against dog infested by tick. A total of 10 dogs weighing about 20-40 kg which consists of various races, were divided into control groups with-out medication (n=2), and treatment group (n=8) received fluralaner tablets once by orally, at a dose of 25 mg / kg body weight. The results showed that based on observation of day of drug application at 24th hour was the time where the drug reaches the standard of efficacy with decrease number of the tick by 97.3%. In 28 and 56 days post treatment were the highest levels of efficacy with a decrease number of tick reaching 100%. The efficacy of the fluralaner was still very high until 84 days post treatment reached up to 94.1%. This study also proved that 12 weeks of drug work believed to overcome reinfestation of the tick. The rapid tick-killing effect and the long duration of efficacy showed the potency fluralaner to aid in the prevention of tick borne diseases.
Downloads
References
Beugnet F, Liebenberg J, Halos L. 2015. Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus. Veterinary Parasitology 209 (1-2): 142–145.
Blagburn BL, Dryden MW. 2009. Biology, treatment and control of flea and tick infestations. Veterinary Clinics: Small Animal Practice 39(6): 1173-1200.
Hadi UK, Soviana S, Pratomo IRC. 2016. Prevalence of ticks and tick-borne diseases in Indonesian dogs. Journal of Veterinary Science and Technology 7(3): 330.
Hadi UK, Soviana S. 2010. Ektoparasit: Pengenalan, Identifikasi dan Pengendaliannya. Bogor (ID): IPB Pr.
Hendricks A, Perrins N. 2007. Recent advances in tick control. In Practice: 29: 284-287.
Jongejan F, Crafford D, Erasmus H, Fourie J, Schunack B. 2016. Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs. Parasites & vectors. 9(1): 348.
Kilp S, Ramirez D, Allan MJ, Roepke R, Nuernberger MC. 2014. Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration. Parasites & vectors 7(1): 85.
Rohdich N, Roepke RKA, Zschiesche E. 2014. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of BravectoTM (fluralaner) against FrontlineTM (fipronil) in flea- and tick-infested dogs. Parasites & vectors 7(1): 83.
Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. 2014. The effect of food on the pharmacokinetics of oral fluralaner in dogs. Parasites & vectors 7(1): 84.
Copyright (c) 2020 CC-BY-SA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.jpg)
